Black Diamond Therapeutics (BDTX) Debt to Equity: 2018-2020

Historic Debt to Equity for Black Diamond Therapeutics (BDTX) over the last 1 years, with Sep 2020 value amounting to $0.00.

  • Black Diamond Therapeutics' Debt to Equity was N/A to $0.00 in Q3 2020 from the same period last year, while for Sep 2020 it was $0.00, marking a year-over-year change of. This contributed to the annual value of -$0.11 for FY2018, which is N/A change from last year.
  • Black Diamond Therapeutics' Debt to Equity amounted to $0.00 in Q3 2020, which was up 1,227.73% from $0.00 recorded in Q2 2020.
  • Over the past 5 years, Black Diamond Therapeutics' Debt to Equity peaked at $0.00 during Q1 2020, and registered a low of -$0.11 during Q4 2018.
  • For the 2-year period, Black Diamond Therapeutics' Debt to Equity averaged around -$0.03, with its median value being $0.00 (2020).